Sponsor-Investigator (GCP) CITI Training FAQs

IRB policy requires mandatory training for investigators who are also serving as sponsors, (e.g., holding an Investigational New Drug (IND), Investigational Device Exemption (IDE), or abbreviated IDE), for an FDA-regulated clinical investigation. A Sponsor-Investigator must complete the applicable drug or device Good Clinical Practice training on CITI before final IRB approval is granted. The ReGARDD Training Modules on IND Sponsor-Investigator Responsibilities [HTML] may be substituted for the CITI GCP course by providing completion documentation to ORI (HSPTrainingSupport@uky.edu).
- If the Sponsor-Investigator has documentation of completion of equivalent training, email course completion documentation to HSPTrainingSupport@uky.edu.
Sponsor-Investigators may also choose to require completion of the training by staff who will be involved in the conduct of the study. This is encouraged for sub-investigators to whom any sponsor responsibilities will be delegated.

You may enroll initially from the Courses page after logging in to your account. Scroll to the bottom of your Courses page then click "Add a Course" under Learner Tools for University of Kentucky.
Select Human Subject Protection (HSP), then click Next.
Select Good Clinical Practice (GCP) training, then click Next.
Select Initial or Refresher, then click Next.
Select applicable course, then click Next.
Initial training:
Or Refresher training:
You are directed back to your Courses page where it states you are now enrolled.

Scroll down to "Courses Ready to Begin" and click Start Now to complete the Initial HSP training.